TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Shareholders’ equity 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.9BFY2025 · since FY2016: $33.3B → $7.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.9B | +47.2% |
| FY2024 | $5.4B | -28.4% |
| FY2023 | $7.5B | -3.8% |
| FY2022 | $7.8B | -24.1% |
| FY2021 | $10.3B | +2.5% |
| FY2020 | $10.0B | -28.2% |
| FY2019 | $14.0B | -5.0% |
| FY2018 | $14.7B | -15.3% |
| FY2017 | $17.4B | -47.9% |
| FY2016 | $33.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice